1. Home
  2. OLP vs PHAR Comparison

OLP vs PHAR Comparison

Compare OLP & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Liberty Properties Inc.

OLP

One Liberty Properties Inc.

HOLD

Current Price

$22.25

Market Cap

502.8M

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

BUY

Current Price

$9.77

Market Cap

793.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
OLP
PHAR
Founded
1982
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.8M
793.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
OLP
PHAR
Price
$22.25
$9.77
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$27.17
★ $34.35
AVG Volume (30 Days)
★ 73.5K
33.9K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 8.14%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.00
N/A
Revenue
★ $82,740,000.00
N/A
Revenue This Year
$11.60
$1.92
Revenue Next Year
$1.95
$8.85
P/E Ratio
★ $22.12
$3,041.22
Revenue Growth
★ 1.02
N/A
52 Week Low
$19.62
$9.62
52 Week High
$25.88
$21.34

Technical Indicators

Market Signals
Indicator
OLP
PHAR
Relative Strength Index (RSI) 27.31 34.60
Support Level $21.29 $9.62
Resistance Level $23.56 $11.60
Average True Range (ATR) 0.38 0.38
MACD -0.02 -0.06
Stochastic Oscillator 24.85 5.44

Price Performance

Historical Comparison
OLP
PHAR

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: